There are two sets of results coming up in the near term
ICS test.
This is the test for patients immune system biological response to Cvac. the previous ICS test was very positive, but the number of patients tested was small. We should be getting the next test result shortly, with a larger sample of patients from within the CAN 003 trial.
CAN003 trial.
The final results for all patients in the Phase 2b trial are due to be presented by Dr Goh at the Euro Cancer Congress on the 1st October, so announcement of the results by the company will most probably be issued to the ASX very shortly prior to that date.
Meanwhile, we have the end of the SPP placement period in mid August and the annual report due around the end of August.
update on results?, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |